Skip to main content
Premium Trial:

Request an Annual Quote

France s ExonHit Raises 30M Euros in Private Financing Round

NEW YORK, Dec. 3 – French genomics company ExonHit Therapeutics said Monday it raised 30 million euros ($26.8 million) in a third round of private financing.

The Paris-based company, which develops therapeutics and diagnostics based on the analysis of alternative splicing events, said that Dresdner Kleinwort Capital of the UK, Danske Bank of Denmark, and France’s LCF E. de Rothschild and Sudinnova participated in the financing round. 

Previous investors BNP-Paribas' Banexi Venture III, CDC Innovation, AGF Private Equity, Oxford Bioscience Partners, and Sofinnova Partners also contributed. 

ExonHit Therapeutics' previously raised 14 million in a second round of financing that closed a little more than one year ago. 

The company said it would use the latest cash infusion to further develop its therapeutics and diagnostics and to bring them through clinical development. 

The company is currently developing treatments for Amyotrophic Lateral Scleroris, or Lou Gehrig’s disease, and other central nervous system afflictions.

Founded in 1997, ExonHit Therapeutics has a US subsidiary in Gaithersburg, Md. The company expects to generate revenues from products and services and anticipates reaching profitability in 2004.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.